Bioprocess plants need modernising to accommodate single-use systems

Morten Munk from the Parenteral Drug Association has said the pharmaceutical industry faces a challenge in making ageing facilities compatible with single-use systems.

The benefits of single-use to industry and patients were numerous, Mr Munk told delegates at the Disposable Solutions for Biomanufacturing Conference in Munich, Germany.
But “ageing” facilities needed rebuilding to stay apace of the growth in single-use systems.
Mr Munk was presenting details of the PDA’s Technical Report 66: Application of Single-Use Systems in Pharmaceutical Manufacturing.
The research, he said, supported the further integration of single-use systems but had also cast light on a number of key challenges.
In addition to modifying the design and operations of bioprocess plants, industry needed to:

• Ensure fully closed systems
• Work towards a standardisation of quality requirements and testing procedures
• Collaborate with industry, suppliers and regulators

Author

Phill Allen

Managing Director

Phill is an innovative thinker particularly in fluid management. His expertise lies in ensuring the seamless flow of pharmaceutical liquid logistics, whether it's optimising current processes or pioneering new approaches.

Follow me